首页> European journal of nuclear medicine and molecular imaging> PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer.

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer.

导出 OA

翻译打印收藏纠错

第一作者： Frederik L,Giesel

第一单位： Department of Nuclear Medicine, INF 400, University Hospital Heidelberg, University of Heidelberg, 69120, Heidelberg, Germany. frederik@egiesel.com.;Cooperation Unit Nuclear Medicine, DKFZ, Heidelberg, Germany. frederik@egiesel.com.

作者： Frederik L,Giesel ^[1] ; H,Fiedler ^[2] ; M,Stefanova ^[2] ; F,Sterzing ^[3] ; M,Rius ^[4] ; K,Kopka ^[5] ; J H,Moltz ^[5] ; A,Afshar-Oromieh ^[2] ; P L,Choyke ^[6] ; U,Haberkorn ^[7] ; C,Kratochwil ^[2]

作者单位： Department of Nuclear Medicine, INF 400, University Hospital Heidelberg, University of Heidelberg, 69120, Heidelberg, Germany. frederik@egiesel.com.;Cooperation Unit Nuclear Medicine, DKFZ, Heidelberg, Germany. frederik@egiesel.com. ^[1] Department of Nuclear Medicine, INF 400, University Hospital Heidelberg, University of Heidelberg, 69120, Heidelberg, Germany. ^[2] Department of RadioOncology, University of Heidelberg, Heidelberg, Germany. ^[3] Institute for Transuranium Elements (ITU), European Commission, Karlsruhe, Germany.;Cooperation Unit Nuclear Medicine, DKFZ, Heidelberg, Germany. ^[4] Radiopharmaceutical Chemistry, German Cancer Research Center (dkfz), Heidelberg, Germany. ^[5] Molecular Imaging Program, National Cancer Institute, Bethesda, USA. ^[6] Department of Nuclear Medicine, INF 400, University Hospital Heidelberg, University of Heidelberg, 69120, Heidelberg, Germany.;Cooperation Unit Nuclear Medicine, DKFZ, Heidelberg, Germany. ^[7]

关键词 68Ga-PSMA-11 PET/CT Lymph node evaluation Lymph node metastasis Recurrent prostate cancer